Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
Exxon Mobil (XOM) and Chevron (CVX) : To the untrained eye, Exxon and Chevron may seem similar. Both companies are huge integrated oil giants, but when they reported earnings this quarter, some stark differences emerged. Chevron beat on both the top and bottom lines, and shares surged 4%, while Exxon missed on the top line and the stock sank 2.5%.
Exxon has always been viewed as a steady operator with a solid dividend, Cramer explained, while Chevron's earnings have been more volatile, causing its dividend to come into question. But this quarter, Chevron not only gave investors a monster 31-cents-a-share earnings beat, but also talked up growth prospects in the Permian Basin.
Exxon, on the other hand, has never been promotional, Cramer said, and the company held true to its nature as it spoke more of accounting issues than growth on its conference call. That led many investors to view Chevron as a reinvigorated growth company with the possibility of doing even better in the future. That makes its shares worth the premium 23 times multiple they currently receive, as compared to Exxon at 19.5 times earnings.
Cramer was also a fan of Chevron's superior 4.1% dividend yield.
Clorox (CLX) : For his "Executive Decision" segment, Cramer spoke again with Benno Dorer, chairman and CEO of Clorox (CLX) , the consumer packaged goods giant which today delivered a six-cents-a-share earnings beat, but saw shares punished 3.2% on its weaker-than-anticipated guidance.
Dorer said that Clorox is seeing strong 3% top-line growth in an environment where growth is hard to come by. He said Clorox has the momentum and is "staying the course."
When asked about increased price competition in come categories, Dorer said that when commodity prices are favorable, some companies will cut prices to gain market share. But over the long-term, this tactic is not sustainable, he said -- which is why Clorox tends to hold prices and take a longer-term view.
Dorer was bullish on his company's acquisition of Renew Life probiotics, saying that while the category is not a needle-mover yet, he expects that it will be as the category now tops $1.3 billion. Dorer was also bullish on social and digital media, saying that Clorox spends more than 40% of its media budget in the category, which delivers the right message to the right customer at the right time.
Cramer said while the packaged goods stocks are out of favor right now on Wall Street, Clorox is the one to own when they do come back into favor.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.